Ann Gidner

Ann Gidner

Amministratore Delegato presso ZICCUM AB
60 anni
Health Technology
Process Industries
Consumer Services

Profilo

Ann Ulrika Gidner is currently Chief Executive Officer at Ziccum AB since 2022.
Former roles include Chief Executive Officer at AcuCort AB, Chief Executive Officer at SelectImmune Pharma AB from 2020 to 2022, Director-Sales & Marketing at LANXESS Deutschland GmbH, Life Science Director at Semcon Caran AB, Director-Sales & Business Development at Novozymes Biopharma Sweden AB, Director at SenzaGen AB from 2014 to 2020, Managing Director at Monocl AB, Director-Business Development at Albumedix A, Independent Director at Iconovo AB, Senior Global Business Development Officer at Cambrex Corp., Principal at LANXESS Corp., Principal at Cambrex AB, and Head-CTS Business Unit at Inceptua GmbH.
Education includes graduate and MBA degrees from the University of Lund.

Posizioni attive di Ann Gidner

SocietàPosizioneInizio
ZICCUM AB Amministratore Delegato 09/05/2022
THOR MEDICAL Direttore/Membro del Consiglio 24/04/2025

Precedenti posizioni note di Ann Gidner

SocietàPosizioneFine
SELECTIMMUNE PHARMA AB (PUBL) Amministratore Delegato 27/04/2022
SENZAGEN AB Direttore/Membro del Consiglio 01/01/2020
Vendite & Marketing -
CAMBREX CORPORATION Corporate Officer/Principal -
ICONOVO AB Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Ann Gidner

Formazione di Ann Gidner

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

38

Relazioni di 1° grado

16

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private16

Health Technology

Process Industries

Consumer Services

Cambrex AB

Process Industries

Industrial Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Commercial Services

  1. Mercati
  2. Insiders
  3. Ann Gidner